Postoperative Rehemorrhage of Minimally Invasive Hematoma Aspiration:Etiological Analysis

Qi-ming LIANG,Feng XU,Li-fei LIAN,Gang WANG,Yi-chi ZHANG,Zheng XUE,Fu-rong WANG,Zhou-ping TANG,Sui-qiang ZHU
DOI: https://doi.org/10.3870/sjsscj.2015.05.006
2015-01-01
Abstract:Objective: To explore the etiology of rehemorrhage after minimally invasive surgery (MIS) combined with recombinant issue plasminogen activator (rt-PA) for hematoma evacuation. Methods: The clinical data of pa-tients with intracerebral hemorrhage treated by MIS plus rt-PA were analyzed retrospectively. Results: One hundred and eighty-three patients were enrolled. The incidence of rehemorrhage was 9.29% and symptomatic rehemorrhage was 1.64%. The rates of puncture injury (include catheter-tract hemorrhage and subarachnoid hemorrhage) was 19.67%, and the 30-d mortality was 4.37%. There was a significantly positive correlation between puncture injury and rehemorrhage (P=0.001). Hypertension(P=0.042) and reposition of catheter (P=0.030) were also significantly associated with rehemorrhage. But aspiration, dosage of rt-PA were not significantly associated with rehemorrhage. The hematoma clearance rate of the patients with liquefaction treatment after rebleeding was (57.32 ± 21.20)%. 23.07% rehemorrhage patients who received sequential thrombolytics had another rehemorrhage. Thirty-day mor-tality of the rehemorrhage patients was 5.88%. Conclusion: MIS plus rt-PA for hemorrhage evacuation is relatively safe with low rehemorrhage rate. Puncture injury and reposition of catheter will increase the risk of rehemorrhage. Low dose of rt-PA can be cautiously used to treat hematoma postoperation. However, the risk of secondary rehem-orrhage need more attention.
What problem does this paper attempt to address?